Back

Viable and efficient electroporation-based genetic manipulation of unstimulated human T cells

Aksoy, P.; Aksoy, B. A.; Czech, E.; Hammerbacher, J.

2019-10-20 immunology
10.1101/466243 bioRxiv
Show abstract

Electroporation is the most feasible non-viral material delivery system for manipulating human T cells given its time- and cost-effectiveness. However, efficient delivery requires electroporation settings to be optimized for different devices, cellular states, and materials to be delivered. Here, we used electroporation to either induce exogenous gene expression in human primary T cells by plasmids or in vitro transcribed (IVT) mRNA and also target endogenous genes by Cas9 ribonucleoproteins (RNPs). We characterized the electroporation conditions both for activated and unstimulated human T cells. Although naive cells are non-dividing and therefore their genetic manipulation is harder compared to activated T cells, we developed the technical ability to manipulate both naive and memory cells within the unstimulated T cell population by IVT mRNA and Cas9 RNP electroporation. Here, we outline the best practices for achieving highly-efficient genetic manipulation in primary T cells without causing significant cytotoxicity to the cells. Because there is increasing evidence for \"less-differentiated\" T cells to have better anti-tumor activity for immunotherapy, manipulating naive T cells with high efficiency is also of high importance to clinical applications and to study the biology of these cells.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Scientific Reports
3612 papers in training set
Top 5%
9.8%
2
STAR Protocols
18 papers in training set
Top 0.1%
6.3%
3
BMC Biotechnology
14 papers in training set
Top 0.1%
5.5%
4
iScience
1154 papers in training set
Top 2%
5.5%
5
Frontiers in Immunology
638 papers in training set
Top 3%
4.3%
6
eLife
5828 papers in training set
Top 29%
4.1%
7
Molecular Therapy - Nucleic Acids
25 papers in training set
Top 0.1%
4.1%
8
Cytotherapy
15 papers in training set
Top 0.1%
3.5%
9
Cell Reports Methods
165 papers in training set
Top 0.6%
3.4%
10
PLOS ONE
5266 papers in training set
Top 37%
3.3%
11
Genes to Cells
25 papers in training set
Top 0.1%
3.3%
50% of probability mass above
12
Biotechnology Journal
11 papers in training set
Top 0.1%
3.2%
13
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.3%
2.4%
14
Journal of Immunological Methods
24 papers in training set
Top 0.1%
2.1%
15
Frontiers in Bioengineering and Biotechnology
98 papers in training set
Top 0.9%
2.1%
16
Life Science Alliance
285 papers in training set
Top 3%
1.7%
17
The CRISPR Journal
39 papers in training set
Top 0.2%
1.7%
18
Cells
249 papers in training set
Top 3%
1.7%
19
Molecular Therapy Nucleic Acids
39 papers in training set
Top 0.6%
1.4%
20
International Journal of Molecular Sciences
494 papers in training set
Top 9%
1.4%
21
Molecular Immunology
14 papers in training set
Top 0.1%
1.3%
22
Vaccines
198 papers in training set
Top 3%
1.1%
23
Stem Cell Reports
130 papers in training set
Top 1%
1.1%
24
Journal of Cell Science
393 papers in training set
Top 3%
1.1%
25
Biosensors and Bioelectronics
57 papers in training set
Top 0.7%
1.0%
26
The FASEB Journal
194 papers in training set
Top 5%
0.8%
27
International Immunopharmacology
15 papers in training set
Top 0.3%
0.8%
28
Biology Open
156 papers in training set
Top 4%
0.6%
29
Analytical Chemistry
218 papers in training set
Top 3%
0.6%
30
Immunology & Cell Biology
11 papers in training set
Top 0.2%
0.6%